STOCK TITAN

4,403 Arvinas (ARVN) shares slated for Rule 144 sale on NASDAQ

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Arvinas, Inc. insider plans small stock sale under Rule 144. A person for whose account the shares are held filed to sell 4,403 shares of Arvinas common stock through Morgan Stanley Smith Barney LLC on or about 02/13/2026 on the NASDAQ market, with an aggregate market value of $52,359.96. These shares were acquired the same day through settlement of vested restricted stock units granted by Arvinas, Inc. The filing notes that shares outstanding were 64,224,294, providing context for the sale’s relative size.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for ARVN disclose?

The Form 144 for ARVN discloses an intended sale of 4,403 shares of Arvinas common stock. The shares are to be sold on NASDAQ through Morgan Stanley Smith Barney LLC, with an aggregate market value of $52,359.96 at the time of the notice.

How many Arvinas (ARVN) shares are planned to be sold under this Form 144?

The filing indicates a planned sale of 4,403 shares of Arvinas common stock. These shares were recently acquired through settlement of vested restricted stock units and are being prepared for sale under Rule 144 on or about February 13, 2026.

What is the aggregate market value of the ARVN shares in this Form 144?

The aggregate market value of the 4,403 Arvinas shares covered by the Form 144 is $52,359.96. This figure reflects the total market value of the shares intended for sale at the time the notice was prepared.

How were the Arvinas (ARVN) shares in this Form 144 acquired?

The Arvinas shares were acquired through settlement of vested restricted stock units on February 13, 2026. The issuer, Arvinas, Inc., delivered 4,403 common shares as part of this settlement, and those shares are now the subject of the planned Rule 144 sale.

What does the Form 144 say about ARVN shares outstanding?

The Form 144 notes that Arvinas, Inc. had 64,224,294 shares of common stock outstanding. This number provides a baseline to gauge the relative size of the 4,403-share sale being prepared under Rule 144 in the filing.

Which broker is handling the planned ARVN share sale in this Form 144?

The planned sale of Arvinas common shares will be handled by Morgan Stanley Smith Barney LLC. The broker’s listed address is 1 New York Plaza, New York, NY 100004, and the transaction is expected to take place on the NASDAQ exchange.
Arvinas

NASDAQ:ARVN

ARVN Rankings

ARVN Latest News

ARVN Latest SEC Filings

ARVN Stock Data

748.21M
59.11M
6.85%
94.18%
11.67%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW HAVEN